 |
|
Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy
A Young Cho, Hyun Ju Yoon, Jung Cheol Lee, Jin Young Kwak, Kwang Young Lee, In O Sun
Kidney Res Clin Pract. 2016;35(4):229-232. Published online 2016 Aug 5 DOI: https://doi.org/10.1016/j.krcp.2016.07.005
|
|
Citations to this article as recorded by
 Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins
Florian Wagenlehner, Ersilia Lucenteforte, Federico Pea, Alex Soriano, Lara Tavoschi, Victoria R. Steele, Anne Santerre Henriksen, Christopher Longshaw, Davide Manissero, Raymond Pecini, Jason M. Pogue
Clinical Microbiology and Infection.2021; 27(5): 671. CrossRef Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function
Saúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, Fernando Caravaca-Fontan, Estefanía Yerovi-León, Aurora Rojo-Sanchis, José M. del Rey, M. Teresa Tenorio, Fernando Liaño
Nefrología (English Edition).2020; 40(6): 647. CrossRef Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function
Saúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, Fernando Caravaca-Fontan, Estefanía Yerovi-León, Aurora Rojo-Sanchis, José M. del Rey, M. Teresa Tenorio, Fernando Liaño
Nefrología.2020; 40(6): 647. CrossRef Changes in Renal Function by Nebulized Colistimethate Treatment
Hye Jin Ahn, Yoo Jin Jung, Jae Song Kim, Soo Hyun Kim, Eun Sun Son
Korean Journal of Clinical Pharmacy.2017; 27(2): 92. CrossRef
|